TrialPloS one2021

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.

Nicola Sweeney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.